BSETrident Texofab LtdMinimalNeutral
Announced Sat, 15 Nov · 16:09 IST

Pursuant to Regulation 30 read with Schedule III Part A Para A and Regulation 47 of SEBI Listing Regulations, we hereby enclose copies of newspaper advertisement published on November 15, ....

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Trident Texofab Limited has submitted copies of a newspaper advertisement published on November 15, 2025 in Financial Express (English and Gujarati editions). The advertisement contains the extract of the company's Un-Audited Standalone Financial Results for the quarter and half year ended September 30, 2025. The disclosure is being made under Regulation 30 read with Schedule III Part A and Regulation 47 of the SEBI Listing Regulations, 2015. The same information is also available on the company's website at www.tridenttexofab.com. The filing is signed by Rahul Jariwala, Company Secretary & Compliance Officer. The company's BSE scrip code is 540726 and ISIN is INE071Y01013.

Likely market impact

This is a routine regulatory compliance filing with no new material information — it merely confirms that the company's Q2 FY26 results, which were already filed with BSE earlier, have now been published in newspapers as required by SEBI rules. No direct impact on shareholders or stock price is expected from this disclosure.